Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A

Yuan LL, Cao CY

Clinical, Cosmetic and Investigational Dermatology 2023, 16:2585-2596

Published Date: 21 September 2023